U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Dexmedetomidine for Sedation in the ICU or PICU: A Review of Cost-Effectiveness and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Dec 17.

Cover of Dexmedetomidine for Sedation in the ICU or PICU: A Review of Cost-Effectiveness and Guidelines

Dexmedetomidine for Sedation in the ICU or PICU: A Review of Cost-Effectiveness and Guidelines [Internet].

Show details

REFERENCES

1.
Reardon DP, Anger KE, Adams CD, Szumita PM. Role of dexmedetomidine in adults in the intensive care unit: an update. Am J Health-Syst Pharm. 2013 May 1;70(9):767–777. [PubMed: 23592359]
2.
PrPrecedex™ (dexmedetomidine hydrochloride for injection): 100 mc/mL in a 2 mL glass vial [product monograph]. Saint-Laurent (QC): Hospira Healthcare Corporation; May 16, 2014.
3.
McKesson Pharmaclick [Internet]. Saint-Laurent (QC): McKesson Canada; 2014. [cited 2014 Dec 15]. Available from: https://www​.mckesson.ca Subscription required.
4.
Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ [Internet] 1996 Aug 3;313(7052):275–283. [cited 2014 Dec 16]; Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles​/PMC2351717/pdf/bmj00553-0039.pdf. [PMC free article: PMC2351717] [PubMed: 8704542]
5.
The AGREE Next Steps Consortium. Appraisal of guidelines for research and evaluation II [Internet]. London (UK): The AGREE Research Trust; May, 2009. [cited 2014 Dec 16]. p. 56. Available from: http://www​.agreetrust​.org/wp-content/uploads​/2013/06/AGREE_II​_Users_Manual_and_23-item​_Instrument_ENGLISH.pdf.
6.
Thoma BN, Li J, McDaniel CM, Wordell CJ, Cavarocchi N, Pizzi LT. Clinical and economic impact of substituting dexmedetomidine for propofol due to a US drug shortage: examination of coronary artery bypass graft patients at an urban medical centre. Pharmacoeconomics. 2014 Feb;32(2):149–157. [PubMed: 24254138]
7.
Patanwala AE, Erstad BL. Comparison of dexmedetomidine versus propofol on hospital costs and length of stay. J Intensive Care Med. 2014 Jul 24 EPub ahead of print. [PubMed: 25061063]
8.
Lachaine J, Beauchemin C. Economic evaluation of dexmedetomidine relative to midazolam for sedation in the intensive care unit. Can J Hosp Pharm [Internet] 2012 Mar;65(2):103–110. [cited 2014 Nov 25]; Available from: http://www​.ncbi.nlm.nih​.gov/pmc/articles/PMC3329902. [PMC free article: PMC3329902] [PubMed: 22529402]
9.
Scottish Medicines Consortium. Dexmedetomidine 100 micrograms/mL concentrate for solution for infusion (Dexdor®) [Internet]. Glasgow: SMC; May 4, 2012. [cited 2014 Dec 3]. p. 10. Available from: http://www​.scottishmedicines​.org.uk/files​/advice/dexmedetomidine​_Dexdor_FINAL_May_2012_for_website​.pdf.
10.
AWMSG Secretariat assessment report (full submission): advice no. 2312: dexmedetomidine (Dexdor®) 100 micrograms/ml concentrate foe solution for infusion. Penarth, Wales, UK: All Wales Therapeutics and Toxicology Centre; May 4, 2014.
11.
Dasta JF, Kane-Gill SL, Pencina M, Shehabi Y, Bokesch PM, Wisemandle W, et al. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med. 2010 Feb;38(2):497–503. [PubMed: 19789442]
12.
Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013 Jan;41(1):263–306. [PubMed: 23269131]
13.
Celis-Rodriguez E, Birchenall C, de la Cal MA, Castorena Arellano G, Hernández A, Ceraso D, et al. Clinical practice guidelines for evidence-based management of sedoanalgesia in critically ill adult patients. Med Intensiva [Internet] 2013 Nov;37(8):519–574. [cited 2014 Dec 17]; Available from: http://www​.medintensiva​.org/en/clinical-practice-guidelines-for-evidence-based​/articulo​/S2173572713001094/ [PubMed: 23773859]
14.
GRADE Working Group. GRADE [Internet]. [place unknown]: The GRADE Working Group; 2010. [cited 2014 Dec 16]. Available from: http://www​.gradeworkinggroup​.org/index.htm.
Copyright © 2014 Canadian Agency for Drugs and Technologies in Health.

Copyright: This report contains CADTH copyright material and may contain material in which a third party owns copyright. This report may be used for the purposes of research or private study only. It may not be copied, posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner.

Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners’ own terms and conditions.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK268702
Contents

Views

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...